Bicycle Therapeutics PLC
NASDAQ:BCYC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
UK |
|
MicroVision Inc
NASDAQ:MVIS
|
US |
|
A
|
Allied Gold Corp
TSX:AAUC
|
CA |
|
A
|
Autozone Inc
DUS:AZ5
|
US |
|
Grifols SA
MAD:GRF
|
ES |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
UK |
|
Dexcom Inc
NASDAQ:DXCM
|
US |
|
Neuronetics Inc
NASDAQ:STIM
|
US |
|
Z
|
Zicix Corp
OTC:ZICX
|
US |
|
Orege SA
F:4ZF
|
FR |
|
B
|
Briacell Therapeutics Corp
TSX:BCT
|
CA |
|
Chemours Co
NYSE:CC
|
US |
|
M
|
Mercadolibre Inc
LSE:0K0E
|
AR |
|
Tenaris SA
BMV:TS
|
LU |
|
Fuji Electric Co Ltd
TSE:6504
|
JP |
|
A
|
Adobe Inc
XHAM:ADB
|
US |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
Bankruptcy Probability
Bicycle Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bicycle Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
259m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
470.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
188.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bicycle Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bicycle Therapeutics PLC has total debt of 551k USD. This includes both short-term (0 USD) and long-term (551k USD) debt.
You can find a full breakdown on its Balance Sheet.